Houston, TX, United States of America

Geneprint Corporation

Calculating rank
USPTO Granted Patents = 3

Forward Citations = 30

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Judith F Margolin (2 out of 2 patents)

silverMedal Marie-Claude Gingras (2 out of 2 patents)

bronzeMedal Harold E Bellis (1 out of 21 patents)

4.  Mark Harry Krackov (1 out of 4 patents)


3 patents:

Company Overview
Geneprint Corporation is a leading biotechnological firm specializing in genetic testing and analysis services. Established in the early 2000s, the company has pioneered advancements in DNA profiling, genetic sequencing, and personalized medicine. By leveraging cutting-edge technology and a skilled team of scientists, Geneprint provides innovative solutions for clinical diagnostics, forensic analysis, and ancestry verification. The company aims to promote health and wellness by enabling individuals and healthcare providers to make informed decisions based on genetic insights. Committed to research and development, Geneprint continues to expand its portfolio of services and remains at the forefront of genomic technologies. With a focus on accuracy, privacy, and customer service, Geneprint Corporation has built a strong reputation in the biotechnology industry.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

3 Patents

#1,215 in Houston, TX

#4,798 in Texas

#73,929 in US

Houston, TX (US)
Houston, TX, United States of America
Forward Citations = 30

4 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Geneprint Corporation. Retrieved from https://idiyas.com/company/geneprint

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…